You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Benazepril hydrochloride - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for benazepril hydrochloride and what is the scope of freedom to operate?

Benazepril hydrochloride is the generic ingredient in four branded drugs marketed by Amneal Pharms, Ani Pharms, Aurobindo Pharma, Chartwell Rx, Corepharma, Genpharm, Heritage Pharma, Prinston Inc, Rising, Sun Pharm Inds Ltd, Teva, Zydus Lifesciences, Validus Pharms, Apotex, Aurobindo Pharma Usa, Mylan Pharms Inc, and Sandoz, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for benazepril hydrochloride. Twenty-seven suppliers are listed for this compound.

Summary for benazepril hydrochloride

US Patents:	0
Tradenames:	4
Applicants:	17
NDAs:	21
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	27
Raw Ingredient (Bulk) Api Vendors:	99
Clinical Trials:	44
Patent Applications:	2,984
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in benazepril hydrochloride?	benazepril hydrochloride excipients list
DailyMed Link:	benazepril hydrochloride at DailyMed

Recent Clinical Trials for benazepril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lupus Research Alliance	Phase 2
Northwell Health	Phase 2
Shanghai Children's Hospital	Phase 2

See all benazepril hydrochloride clinical trials

Pharmacology for benazepril hydrochloride

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors
Physiological Effect	Decreased Blood Pressure

US Patents and Regulatory Information for benazepril hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Validus Pharms	LOTENSIN	benazepril hydrochloride	TABLET;ORAL	019851-004	Jun 25, 1991	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Prinston Inc	BENAZEPRIL HYDROCHLORIDE	benazepril hydrochloride	TABLET;ORAL	076118-004	Feb 11, 2004	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Heritage Pharma	BENAZEPRIL HYDROCHLORIDE	benazepril hydrochloride	TABLET;ORAL	076267-003	Feb 11, 2004	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Chartwell Rx	BENAZEPRIL HYDROCHLORIDE	benazepril hydrochloride	TABLET;ORAL	076402-002	Feb 11, 2004	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for benazepril hydrochloride

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Validus Pharms	LOTENSIN	benazepril hydrochloride	TABLET;ORAL	019851-003	Jun 25, 1991	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOTENSIN	benazepril hydrochloride	TABLET;ORAL	019851-004	Jun 25, 1991	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOTENSIN	benazepril hydrochloride	TABLET;ORAL	019851-001	Jun 25, 1991	⤷ Try a Trial	⤷ Try a Trial
Validus Pharms	LOTENSIN	benazepril hydrochloride	TABLET;ORAL	019851-002	Jun 25, 1991	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.